Company
GRAIL
GRAIL develops blood-based cancer screening tests using next-generation sequencing and machine learning to detect multiple cancer types early. The company's Galleri test is designed to identify cancer signals before symptoms appear through analysis of cell-free DNA. GRAIL serves healthcare systems and patients globally, backed by extensive clinical studies involving hundreds of thousands of participants.
GRAIL is a publicly traded company operating in the biotech & pharma sector, based in USA. Leadership tracked by CEOInsider includes Jeff Huber (CEO).
Leadership
Current
